Kurashiki Central Hospital, Okayama, Japan.
Toyohashi Heart Center, Aichi, Japan.
JACC Cardiovasc Interv. 2024 Jun 10;17(11):1374-1384. doi: 10.1016/j.jcin.2024.03.023. Epub 2024 May 1.
Despite the effectiveness of the retrograde approach for chronic total occlusion (CTO) lesions, there are no standardized tools to predict the success of retrograde percutaneous coronary intervention (PCI).
The aim of this study was to develop a prediction tool to identify CTO lesions that will achieve successful retrograde PCI.
This study evaluated data from 2,374 patients who underwent primary retrograde CTO-PCI and were enrolled in the Japanese CTO-PCI Expert Registry between January 2016 and December 2022 (NCT01889459). All observations were randomly assigned to the derivation and validation cohorts at a 2:1 ratio. The prediction score for guidewire failure in retrograde CTO-PCI was determined by assigning 1 point for each factor and summing all accrued points.
The JR-CTO score (moderate-severe calcification, tortuosity, Werner collateral connection grade ≤1, and nonseptal collateral channel) demonstrated a C-statistic for guidewire failure of 0.72 (95% CI: 0.67-0.76) and 0.71 (95% CI: 0.64-0.77) in the derivation and validation cohorts, respectively. Patients with lower scores had higher guidewire and technical success rates and decreased guidewire crossing time and procedural time (P < 0.01).
The JR-CTO (Japanese Retrograde Chronic Total Occlusion) score, a simple 4-item score that predicts successful guidewire crossing in patients undergoing retrograde CTO-PCI, has the potential to support clinical decision-making for the retrograde approach.
尽管逆行技术对于慢性完全闭塞(CTO)病变是有效的,但目前还没有标准化的工具来预测逆行经皮冠状动脉介入治疗(PCI)的成功率。
本研究旨在开发一种预测工具,以识别能够成功进行逆行 PCI 的 CTO 病变。
本研究评估了 2374 名接受原发性逆行 CTO-PCI 并于 2016 年 1 月至 2022 年 12 月期间参加日本 CTO-PCI 专家登记处的患者的数据(NCT01889459)。所有观察结果以 2:1 的比例随机分配到推导和验证队列中。逆行 CTO-PCI 中导丝失败的预测评分是通过为每个因素分配 1 分并累计所有得分来确定的。
JR-CTO 评分(中重度钙化、迂曲、Werner 侧支连接等级≤1 和非间隔侧支通道)在推导和验证队列中导丝失败的 C 统计量分别为 0.72(95%CI:0.67-0.76)和 0.71(95%CI:0.64-0.77)。得分较低的患者导丝和技术成功率较高,导丝穿越时间和手术时间减少(P<0.01)。
JR-CTO(日本逆行慢性完全闭塞)评分是一种简单的 4 项评分,可预测接受逆行 CTO-PCI 的患者导丝成功穿越的可能性,有可能为逆行方法的临床决策提供支持。